Archive for September, 2021

$FNGR Poised to Lead a Post-Pandemic Insurance Industry Renaissance in China

  • A 2020 Deloitte China report noted that big data will be vital in ensuring insurance survive for longer post-pandemic and accelerate their transformation towards excellence
  • Big data is instrumental in facilitating greater product innovation and pricing accuracy for insurers
  • Through its Big Data Insights division (Sapientus), FingerMotion appears well positioned as an ideal partner for insurers looking to implement Deloitte’s proposals
  • The China Banking and Insurance Regulatory Commission recently scrapped the 51% cap on foreign ownership, setting the stage for potential growth of the country’s insurance sector

Last year, Deloitte China released a report titled “COVID-19 and China’s Insurance Industry” that explored the measures insurers have taken to deal with the pandemic, the macro impact of COVID-19 on the insurance industry, and, lastly, how insurance companies should accelerate their transformation towards excellence (https://ibn.fm/U2kpn). The report noted that big data, which some insurers were already using as early as February 2020, will be instrumental in the post-pandemic insurance world.

According to Deloitte China, the pandemic posed a significant challenge to the adaptability and resilience of insurance companies and their management teams. This means that these firms need to consider building sustainable management systems to ensure longevity moving forward. The report proposed that insurers should apply big data to facilitate product differentiation and build digital operational capabilities.

With mechanisms already in place, having launched its Big Data Insights division (Sapientus) in July 2020 and subsequently partnered with Pacific Life Re-Insurance, evolving technology company FingerMotion (OTCQX: FNGR) appears poised as an ideal partner for insurers looking to implement Deloitte China’s proposals.

Speaking in an August 25 corporate update, FingerMotion CEO Martin Shen noted that Sapientus stands out because of its ability to integrate publicly available data into proprietary risk matrices with behavioral indicators derived from event-driven or contextual-based information. Through the provision of behavioral analytics, FNGR is looking to supply actionable intelligence and enable efficient service delivery to potential clients within the insurance industry (https://ibn.fm/AaV8x).

Incidentally, the Deloitte report had alluded to this particular application of big data. It recommended that insurers should make full use of data from external and internal sources to “facilitate quantitative models for customer segmentation, and thus more accurate pricing and greater product innovation.”

FingerMotion’s efforts in the insurance sector coincide with a recent move by the China Banking and Insurance Regulatory Commission (“CBIRC”) to scrap the 51% cap on foreign ownership in insurance businesses in a bid to open up the domestic insurance market and expand the sector (https://ibn.fm/WJ936).

In its analysis, Mordor Intelligence quoted the resultant potential increase in the number of insurance companies in China due to CBIRC’s move as one of the factors expected to help the sector grow even further. The market research company projects that China’s life and non-life insurance market will grow at a 6% CAGR from 2020 to 2025 (https://ibn.fm/jCqxM). At the same time, the online insurance market is expected to grow at a 41% CAGR from 2019 through 2024 (https://ibn.fm/9O90d).

FingerMotion is a technology company with core competencies in SMS/MMS services, mobile payment and recharge solutions, and big data insights. It is also targeting the burgeoning rich communication services (“RCS”) segment, with the expectation that RCS will form the company’s fourth division once launched.

For more information, visit the company’s website at www.FingerMotion.com.

NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

About ChineseWire

ChineseWire (CW) is a specialized communications platform focused on promising China-based companies that are listed in North America. As one of 40+ brands within the InvestorBrandNetwork (“IBN”), CW provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution to IBN’s millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, CW is uniquely positioned to best serve private and public Chinese companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CW brings its clients unparalleled visibility, recognition and brand awareness. CW is where news, content and information converge.

For more information, please visit https://www.ChineseWire.com

Please see full terms of use and disclaimers on the ChineseWire website applicable to all content provided by CW, wherever published or re-published: http://IBN.fm/Disclaimer

ChineseWire (CW)
Los Angeles, California
www.ChineseWire.com
310.299.1717 Office
Editor@ChineseWire.com

ChineseWire is part of the InvestorBrandNetwork.

Wednesday, September 22nd, 2021 Uncategorized Comments Off on $FNGR Poised to Lead a Post-Pandemic Insurance Industry Renaissance in China

$VVOS Four Lifestyle Changes That May Benefit Individuals with Sleep Apnea

Sleep apnea is a common and serious sleep disorder that affects an individual’s breathing during sleep. Undiagnosed and untreated sleep apnea can worsen an individual’s mood, raise their blood pressure and even stress the heart.

Some people suffering from this disorder use a device known as a continuous positive airway pressure device, which enables easier breathing.

However, making some lifestyle changes may also help sleep apnea patients sleep better. Below are a few changes that may be beneficial to patients with sleep apnea.

Avoid some medications

Opioids are known to relax the body’s breathing muscles and slow down an individual’s breathing rate. Patients with sleep apnea are advised to be extra careful when using these painkillers. Other medications that may impact sleep apnea include atypical antipsychotics, testosterone, muscle relaxers and high-dose benzodiazepines.

Quit drinking

The use of alcohol is known to make obstructive sleep apnea worse for various reasons, including the fact that it decreases the tone of the breathing muscles in the upper airway. Additionally, individuals who drink a lot of alcohol usually put on weight. Northwestern Medicine sleep medicine specialist Kuljeet Gill recommends that patients give up alcohol completely.

If you can’t do so, it is recommended that you limit the use of alcohol to weekends and stop drinking at least four hours before going to bed. If you’re a heavy drinker, you’re advised to try and cut back on your intake. This will help lessen the negative impact of alcohol on your sleep apnea.

Exercise more

Physicians have found that physically inactive individuals have a higher risk of developing sleep apnea. Incorporating more exercise into one’s routine helps shed fat around the upper airway. This is in addition to improving an individual’s sleep quality, helping them feel less sleepy, boosting oxygen levels and lessening the severity of one’s sleep apnea.

Yale Medicine sleep specialist Meir Kryger states that even without shedding weight, regular movement can also increase an individual’s energy levels and boost overall health. While more research is needed to determine exactly how exercise helps with sleep apnea, physicians recommend exercise for half an hour every day, for five days a week.

Lose weight

This sleep disorder is more common in obese adults because extra fat tissue blocks the upper airways. An expert in sleep-related breathing disorders from Yale Medicine, Christine Won explains that losing weight can lessen how bad obstructive sleep apnea symptoms are in some patients. However, she notes, it doesn’t eliminate the need for a continuous positive airway pressure device, or CPAP.

In addition to this, patients with sleep apnea can also benefit from changing their sleeping positions and practicing good sleeping habits, including going to bed at the same time every day, etc.

While implementing lifestyle changes may help in the management of obstructive sleep apnea, patients still require treatments such as those made by Vivos Therapeutics Inc. (NASDAQ: VVOS) in order to have a better quality of life despite an OSA diagnosis.

NOTE TO INVESTORS: The latest news and updates relating to Vivos Therapeutics Inc. (NASDAQ: VVOS) are available in the company’s newsroom at http://ibn.fm/VVOS

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Friday, September 10th, 2021 Uncategorized Comments Off on $VVOS Four Lifestyle Changes That May Benefit Individuals with Sleep Apnea

$IZOZF Nominated in Best and Brightest in Medical Imaging Award Campaign

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) is commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers. The company has announced its receipt of a semifinalist nomination for AuntMinnie.com’s 2021 award campaign to recognize the best and brightest in medical imaging. According to the update, Auntminnie.com, a leading radiology news website, has recognized Izotropic’s IzoView Breast CT System in the Best New Radiology Device category. The company congratulates all other nominees and thanks all of those who have and continue to work on IzoView, attributing this nomination to a combined passion and commitment to improving the outcomes of women’s breast cancer.

To view the full press release, visit https://ibn.fm/Ajci1

About Izotropic Corporation

Izotropic Corporation is the only publicly traded company commercializing a dedicated breast CT imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers. To expedite patient and provider access to IzoView, Izotropic’s initial clinical study intends to demonstrate superior performance of diagnostic breast CT imaging over diagnostic mammography procedures and will initiate in Q2 2022. In follow-on clinical studies, Izotropic intends to validate platform applications including breast screening in radiology, treatment planning and monitoring in surgical oncology, and breast reconstruction and implant monitoring in plastic and reconstructive surgery. IzoView produces high resolution breast images in true 3D and is ideal for imaging patients with dense breast tissue. A single 10 second scan acquires approximately 500 images without painful breast compression or continual technician breast handling, providing a more comfortable patient experience with low radiation dose levels. In addition to improved detection capabilities, Izotropic anticipates IzoView’s higher-resolution 3D images could provide more accurate margin analysis (viewing edges of a tumor), lesion characterization (determining the qualities of an abnormality), and higher spatial resolution (the imaging ability to differentiate between internal breast structures). More information about Izotropic can be found on its website at IzoCorp.com and by reviewing its profile on SEDAR at sedar.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, September 9th, 2021 Uncategorized Comments Off on $IZOZF Nominated in Best and Brightest in Medical Imaging Award Campaign

$LEXX to Address Advances in its Bioavailability Technology DehydraTECH(TM) at Wainwright Life Sciences Conference

  • Drug delivery technology innovator Lexaria Bioscience is celebrating the positive outcomes of clinical testing of its trademarked DehydraTECH platform for reducing the blood stream delivery time of anti-virals, NSAIDS and potential hypertension treatments
  • Lexaria will participate in H.C. Wainwright’s annual Global Investor Conference this month to help bring further attention to its successes
  • The DehydraTECH technology enhances the delivery of pharmaceuticals that can be administered orally, and testing has shown no adverse chemical compounds have been created in the process
  • The COVID-19 pandemic has raised the profile of the anti-viral medication market, enhancing the opportunities for Lexaria’s revenue stream

As life sciences technology innovator Lexaria Bioscience (NASDAQ: LEXX) takes a leap forward in R&D programs demonstrating the effectiveness of its trademarked oral substance delivery platform, the company is preparing to join other participants in the 23rd annual Global Investor Conference hosted by full-service investment bank H.C. Wainwright & Co.

The investor conference scheduled Sept. 13-15 will be a hybrid online and in-person gathering of companies enjoying opportunities for platform presentations, one-on-one meetings with investors, and networking with other attendees (https://cnw.fm/lKu67). Lexaria’s CEO, Chris Bunka, will be making the company’s presentation, which will be available to attendees on Monday September 13th.

Lexaria’s recent strides in developing and testing its oral delivery platform DehydraTECH include its successful 2021 antiviral drug program, which has produced data showing DehydraTECH can enhance antiviral drugs’ ability to reach the bloodstream so that they can safely and more effectively do what they are designed to accomplish.

DehydraTECH processed substances such as pharmaceutical drugs enhance their bioavailability, and the clinical trials have also demonstrated that DehydraTECH does not alter nor degrade the drug molecules chemically as to create new molecular entities (“NMEs”) that would create new regulatory concerns for the finished products (https://cnw.fm/XpgtC).

H.C. Wainwright has a history of leading investment transaction volumes ranked by market research service PlacementTracker. Wainwright has consistently placed first among investment banks for confidentially marketed public offerings, registered direct and private placement transactions, according to the analysts (https://cnw.fm/lb7sf).

The September event will include a panel discussion with former Food and Drug Administration Commissioner Scott Gottlieb (2017-2019), who is a member of the board of directors of drug maker Pfizer, Inc., and is preparing to roll out his long-awaited book, “Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic,” this month.

The antiviral medication market has gained particular attention during the ongoing COVID-19 pandemic, and Lexaria’s DehydraTECH is in a position to potentially bring in significant revenues in partnership with the antiviral medications as well as NSAIDs and products that target hypertension and alternative nicotine products — an opportunity the company has been mindful of.

The potential for using DehydraTECH in conjunction with cannabidiol (“CBD”) to target hypertension is one of the sectors of Lexaria’s research gaining attention following the results of a recent study showing DehydraTECH-processed CBD generated a rapid and sustained drop in blood pressure among study participants (https://cnw.fm/E8fpS).

“Lexaria was also pleased that its DehydraTECH-CBD was well tolerated by all subjects, with no serious adverse events or side effects observed or reported. Ingestion of the concentration-matched, generic CBD control, on the other hand, resulted in unwanted side effects in some of the volunteers,” the company’s news release states. “These findings corroborate what Lexaria has previously evidenced in other unrelated studies whereby human volunteers have also experienced reduced side effects with DehydraTECH-processed test articles compared to concentration-matched, generic controls.”

A second human clinical hypertension study of DehydraTECH’s capabilities is under way, and a third study is planned this year once the results of the first two studies are carefully evaluated and considered.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

Thursday, September 9th, 2021 Uncategorized Comments Off on $LEXX to Address Advances in its Bioavailability Technology DehydraTECH(TM) at Wainwright Life Sciences Conference

$FNGR Sees Growing Potential in China’s Insurance Market

  • U.S.-based data tech company FingerMotion is focused on the market potential of Chinese companies’ need for rich communication services (“RCS”) and big-data insights
  • FingerMotion has been particularly focused on the insurance industry’s need for data analysis in recent months, particularly in light of China’s early-stage structure for credit and risk assessment among consumers
  • FingerMotion’s Sapientus platform provides predictive services for risk assessment, spawning a landmark agreement with Pacific Life Re-insurance’s insurtech solutions in China
  • Because China regards insurance as compulsory for sectors such as pension protection, medical care, job hazards, unemployment and maternity care, the potential for insurance services is high in a country that boasts the largest population on the planet

China-focused communications technology company FingerMotion (OTCQX: FNGR) is using big data and analytical technology to provide its clients with market insights as a growing number of Chinese consumers adopt online insurance products.

Last year, online insurance premiums surpassed 290 billion yuan (US$44.8 million) in the country, according to the Google translation of a Gold Investment Network insurance news release (https://ibn.fm/7g2lO). The popularity of online premiums among consumers fueled a rapid surge in new economic activity within the country that continues on an upward path as businesses turn to big data, cloud computing, artificial intelligence (“AI”), and other value-added technology to accelerate their revenues (https://ibn.fm/IDXw7).

FingerMotion has seen its revenues grow in consecutive reporting quarters during the past year (https://ibn.fm/Yg42v) and is anticipating further success thanks in part to a landmark agreement with Pacific Life Re-insurance that effectively positions FingerMotion as Pacific Life’s data provider, utilizing FingerMotion’s trademarked Sapientus platform.

Pacific Life is one of the world’s top five Insurance companies, well into its second century with $1.1 trillion in life insurance policies and $171 billion in assets (https://ibn.fm/DYI95). The company is on a trajectory to firmly bring its services ashore among China’s world-leading population, where consumers are required to carry social insurance and certain types of commercial insurance.

Social insurance covers basic insurance policies for pensions, medical care, on-the-job injuries, unemployment, and maternity care, among other things. The China Banking and Insurance Regulatory Commission (“CBIRC”) is responsible for oversight of insurance and re-insurance regulation, and foreign companies must meet conditions for CBIRC’s approval (https://ibn.fm/gFBMF).

Because China’s credit and insurance risk standards are still in a nascent stage, the predictive solutions offered by FingerMotion’s analytical technology and its big consumer data access provide clients such as Pacific Life a means of anticipating their risks with policy holders.

The predictive services of FingerMotion’s Sapientus database are focused on the insurance industry, but may yet become integral to solutions in other industries as well, such as in varied health care, financial services and consumer e-commerce sectors.

For more information, visit the company’s website at www.FingerMotion.com.

NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

About ChineseWire

ChineseWire (CW) is a specialized communications platform focused on promising China-based companies that are listed in North America. As one of 40+ brands within the InvestorBrandNetwork (“IBN”), CW provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution to IBN’s millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, CW is uniquely positioned to best serve private and public Chinese companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CW brings its clients unparalleled visibility, recognition and brand awareness. CW is where news, content and information converge.

For more information, please visit https://www.ChineseWire.com

Please see full terms of use and disclaimers on the ChineseWire website applicable to all content provided by CW, wherever published or re-published: http://IBN.fm/Disclaimer

ChineseWire (CW)
Los Angeles, California
www.ChineseWire.com
310.299.1717 Office
Editor@ChineseWire.com

ChineseWire is part of the InvestorBrandNetwork.

Thursday, September 9th, 2021 Uncategorized Comments Off on $FNGR Sees Growing Potential in China’s Insurance Market

$RWBYF Builds Out New Florida Facility for Edibles Production

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a leading provider of cannabis brands in the United States, announced that it has built-out a new production facility. The facility meets GMP specifications and enables the company to capitalize on the expanding cannabis derivative market in Florida. The new 4,800-square-foot structure is located at RWBYF’s Sanderson, Florida, location and was built to meet the fast-growing demand for edibles. According to a BDSA report, the state’s medical cannabis market has been projected to reach $1.5 billion in sales in 2021, which would be a 53% increase compared to 2020 numbers; the same report noted that, with both recreational and medical cannabis expected to be legal in Florida by 2023, the market is forecast to total $2.6 billion by 2026. Red White & Bloom is working on the development of a branded capsule and rosin line along with an exclusive line of chocolates that the company anticipates will be available later this year. “We are very pleased to have completed this state of the art production facility ahead of time and begin production this month,” said Red White & Bloom general manager Jim Frazier in the press release. “We will begin with premium specialized confectionary offerings as finished retail-ready packages where medical patients will be able to select from a variety of different products. We are confident this new facility, coupled with our expert staff of edible specialists, can produce a market-leading offering.”

To view the full press release, visit https://ibn.fm/HI5k8

About Red White & Bloom Brands Inc.

Red White & Bloom Brands is positioning itself to be one of the top-three, multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on major U.S. markets, including Michigan, Illinois, Florida, Arizona and California, with respect to cannabis, as well as the United States and internationally for hemp-based CBD products. For more information about the company, please visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at http://ibn.fm/RWBYF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, September 9th, 2021 Uncategorized Comments Off on $RWBYF Builds Out New Florida Facility for Edibles Production

$IDEX New Process Could Halt Permanent Energy Loss from Batteries

With several territories around the world striving for a future where zero-emission electric cars make the majority of vehicles on the road, battery makers are consistently working to make batteries more energy dense and efficient. Electric vehicles (“EVs”) rely on rechargeable lithium-ion batteries for power rather than internal combustion engines (“ICE”), which comes with a set of challenges unique to rechargeable electronic devices such as mobile phones, laptops and EVs. For starters, while most electronic devices indicate that they are 100% when fully charged, this usually represents just 70% to 90% of their theoretical energy-holding capacity. The rest is lost even before the batteries leave the factory, meaning electric vehicles are potentially losing out on tons of mileage before they even hit the road.

This energy density is lost during the production process when batteries go through the first charge during the stabilization stage and permanently lose lithium ions. The initial loss of lithium ions during the production period eventually reduces the mileage of EVs, hindering the public and private sector’s efforts to combat range anxiety and boost EV adoption.

Looking to provide a fix for this issue and allow batteries to access 100% of their energy capacity, a team of researchers from the Korea Institute of Science and Technology (“KIST”) partnered with other experts and ran a range of experiments. Led by Dr. Minah Lee from the Energy Storage Research Center, Dr. Hyangsoo Jeong from the Center for Hydrogen-Fuel Cell Research and Dr. Jihyun Hong from the Center for Energy Storage Research, the team developed an electrode pretreatment solution with the ability to minimize the initial lithium-ion loss experienced by anodes made of graphite-silicon oxide.

Normally, anodes consist mainly of graphite, but the researchers used a new graphite-silicon oxide (“SiOx”) formulation that has been gaining popularity in the recent past, thanks to its much higher energy density. These graphite-silicon oxide anodes have five to ten times more capacity, and when they are dipped in the electrode pretreatment mixture, the initial lithium-ion loss becomes almost negligible.

However, while SiOx anodes have up to 10 times more energy capacity, a higher ratio of silicon oxide in the formulation corresponds with a spike in the initial Li-ion loss. For instance, increasing the ratio of SiOx in the graphite-SiOx composite electrode to 50% resulted in an initial lithium-ion loss of 40%, so the researchers opted for a 15% SiOx ratio. Consequently, the composite anode showed an initial efficacy of nearly 100% after being exposed to the pretreatment mixture. As a result of the study, battery makers are one step closer to producing lithium-ion batteries with greater capacity, says Lee.

As efforts are invested towards improving battery technology and companies such as Ideanomics Inc. (NASDAQ: IDEX) look into developing advanced EV charging technologies, the years ahead could unveil a lot of positives in the EV sector.

NOTE TO INVESTORS: The latest news and updates relating to Ideanomics Inc. (NASDAQ: IDEX) are available in the company’s newsroom at https://ibn.fm/IDEX

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Thursday, September 9th, 2021 Uncategorized Comments Off on $IDEX New Process Could Halt Permanent Energy Loss from Batteries

$SVFD Receives Patent for Proprietary Compound from European Office

Save Foods (NASDAQ: SVFD), an agri-food-tech company focused on developing and selling eco-friendly products specifically designed to extend the shelf life and ensure food safety of fresh fruits and vegetables, announced that the European patent office had approved its application for processes related to core technology; that approval expands the company’s protection of its proprietary compounds for the natural protection of edible matter. According to the announcement, the board approved the validation in Spain, France, Germany and the United Kingdom. The patent covers Save Foods’ proprietary blend of organic food acids that reduces the need for conventional post-harvest fungicide by at least 50% and even entirely, in some cases; in addition, the blend has been shown to reduce food waste due to spoilage by up to 50%. Crops currently being treated include citrus fruit, avocado, pears, mango and bell peppers, and account for billions of dollars in sales around the world. “In the EU, approximately 90 million tons of food waste are generated annually — that’s about 20% of all food produced,” said Save Foods vice president of R&G Dr. Neta Matis in the press release. “This, plus the continued and growing demand for natural, high-quality and sustainable food make the EU a considerable opportunity for Save Foods. With this award, we have secured protection in all key European markets. Our intellectual property portfolio now includes seven issued patents, one allowed and seven pending applications in Israel, the United States and Europe, four of which may be submitted worldwide, with expiration dates ranging from 2031 through 2041.”

To view the full press release, visit https://ibn.fm/eXXt3

About Save Foods Inc.

Save Foods is an innovative, dynamic company addressing two of the most significant challenges in the agri-food-tech industry: food waste and loss, and food safety. The company is dedicated to delivering integrated solutions for improved safety, freshness and quality, every step of the way from field to fork. Collaborating closely with its customers, Save Foods develops new solutions that benefit the entire supply chain and improves the safety and quality of life of both workers and consumers alike. SVFD’s initial applications are in post-harvest treatments in fruit and vegetable packing houses processing, including citrus, avocado, mango, pears, bell peppers and mangos. By controlling and preventing pathogen contamination and significantly reducing the use of hazardous chemicals and their residues, Save Foods products not only prolong fresh produce shelf life and reduce food loss and waste, they also ensure a safe, natural and healthy product. For more information about the company, visit www.SaveFoods.co.

NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at http://ibn.fm/SVFD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, September 9th, 2021 Uncategorized Comments Off on $SVFD Receives Patent for Proprietary Compound from European Office

$UUUU Playing Essential Role in US Efforts to End Dependence on China for REEs

Energy Fuels (NYSE American: UUUU) (TSX: EFR) may be the only company outside of China with the equipment, expertise and licenses in place to responsibly process monazite, one of the most valuable rare earth elements (“REEs”) in the world. A recent article reads, “The company, along with key partners, is focused on establishing the United States again as a producer of advanced rare earth products, all produced from monazite, with a commitment to sustainability, environmental protection and human rights. The company is also creating a supply chain option that allows monazite suppliers in the U.S. and around the world to participate in the profits from downstream rare earth processing and production of advanced materials.” This comes in the wake of the commitment by the U.S. government to end the country’s dependence on China for REEs. According to Energy Fuels, China dominates every aspect of the global rare earth market, from mining to processing to manufacturing. China has wielded this monopoly of the REE supply chain to influence foreign policies, a weaponization that threatens the economic and national security of the U.S. and other countries around the world. As a result, Energy Fuels’ involvement in this effort is essential.

To view the full article, visit https://ibn.fm/BkDIh

About Energy Fuels Inc.

Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant, and is ramping up to commercial production of REE carbonate in 2021. Its corporate offices are in Lakewood, Colorado, near Denver, and all of its assets and employees are in the United States . Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year and has the ability to produce vanadium when market conditions warrant, as well as REE carbonate and uranium from various uranium-bearing ores. The Nichols Ranch ISR Project is currently on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also on standby and has a licensed capacity of 1.5 million pounds of U3O8 per year. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol UUUU, and the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol EFR. For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About MiningNewsWire

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

Thursday, September 9th, 2021 Uncategorized Comments Off on $UUUU Playing Essential Role in US Efforts to End Dependence on China for REEs

$TOBAF to Showcase Brand Among Several ‘Big Tobacco’ Firms at Prestigious Conference

TAAT(TM) (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) today announced that it will be an exhibitor at the 2021 NACS Show slated to be held from Wednesday, Oct. 6, 2021, through Friday, Oct. 8, 2021, in Chicago, Illinois. The event will draw approximately 1,200 vendors in the convenience category to welcome an average of 23,000 attendees from more than 70 countries*. The NACS Show is operated by the Association for Convenience & Fuel Retailing (formerly known as the National Association of Convenience Stores, abbreviated “NACS”), a trade association established in 1961 currently focused on industry-related issues such as labor and health care benefits, menu labelling compliance, payment card swipe fees, and tobacco retailing regulations**. “Trade shows have proven highly effective for us ever since they became part of our commercialization strategy this summer. Although we have had no difficulty navigating the sales and distribution channels through direct outbound contacts, trade shows provide unparalleled opportunity to immerse buyers, merchandisers and distributors in the TAAT brand,” the company’s CEO Setti Coscarella said in the press release. “Our trade show displays are creatively designed to convey that TAAT is a combustible product used by smokers aged 21+ in a nearly identical fashion to a traditional tobacco cigarette, except with no nicotine or tobacco. This engaging experience has proven instrumental to maintaining a high conversion rate. Now that we have managed to perfect our trade show playbook, we’re taking things further by exhibiting at the most prestigious conference in the convenience industry on the same floor as the ‘Big Tobacco’ firms. We are looking forward to this three-day event, where we expect to make many important connections in our journey to keep gaining market share in the USD $814 billion global tobacco industry.”

To view the full press release, visit https://ibn.fm/RtIWA

About TAAT Global Alternatives Inc.

The company has developed TAAT(TM), which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco(TM), a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with “Big Tobacco” pedigree, TAAT was launched first in the United States in Q4 2020 as the company seeks to position itself in the $814 billion global tobacco industry. For more information, please visit www.TAATGlobal.com.

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at http://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, September 9th, 2021 Uncategorized Comments Off on $TOBAF to Showcase Brand Among Several ‘Big Tobacco’ Firms at Prestigious Conference

$WTER Announced as Participant at H.C. Wainwright Global Investment Conference

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER)the country’s largest independent alkaline water company, will be featured at this year’s 23rd annual H.C. Wainwright Global Investment Conference. The three-day, virtual conference is scheduled for Sept. 13–15, 2021. WTER president and CEO Ricky Wright will present during the conference; his presentation will be available beginning Sept. 13. Wright’s presentation will include a look at the company’s most recent highlights and accomplishments as well as a discussion regarding WTER’s future strategy and outlook. In addition, members of the company’s management team will also be available for virtual meetings with qualified investors attending the conference.

To view the full press release, visit https://ibn.fm/PnM3r

About The Alkaline Water Company Inc.

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88(R) delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts the company’s trademarked Clean Beverage label. Quickly recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused(TM) flavored water is available in six unique all-natural flavors, with new flavors coming soon. In 2021, The Alkaline Water Company was pleased to welcome Shaquille O’Neal to its board of advisors and as a celebrity brand ambassador for the Alkaline88 and A88 Infused brands. To learn more about the company, please visit www.Alkaline88.com and www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, September 9th, 2021 Uncategorized Comments Off on $WTER Announced as Participant at H.C. Wainwright Global Investment Conference

$CYBN CEO to Present Virtually at H.C. Wainwright 23rd Annual Global Investment Conference

Cybin (NEO: CYBN) (NYSE American: CYBN), a life sciences company focused on advancing psychedelic pharmaceutical therapeutics for various psychiatric and neurological conditions, today announced that on Monday, September 13, 2021, Chief Executive Officer Doug Drysdale will be presenting virtually at the H.C. Wainwright 23rd Annual Global Investment Conference. The presentation will be webcast on-demand beginning at 7:00 AM ET on September 13, and will be available for 90 days at https://ibn.fm/cWDdt

To view the full press release, visit https://ibn.fm/5C0d9

About Cybin Inc.

Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at http://ibn.fm/CYBN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, September 9th, 2021 Uncategorized Comments Off on $CYBN CEO to Present Virtually at H.C. Wainwright 23rd Annual Global Investment Conference

$FLGC Inks Euro2M Investment in Hoshi As Part of its European Expansion Plan

  • Flora closed a €2 million investment in Hoshi International Inc., fulfilling the earlier-announced LOI back in June 2021
  • This move is set to capitalize on Hoshi’s strong European presence, its technical know-how along with its understanding of the European market
  • Hoshi acknowledged the investment with the announcement that it would work together with Flora to bring to market finished product formats from Flora’s brand portfolio
  • Flora referred to this investment as the first of many steps by the company to advance its plans to launch products across the world

On August 24, 2021, Flora Growth (NASDAQ: FLGC) announced closing a €2 million investment in Hoshi International Inc. It also announced that it had increased its fully-diluted ownership in Hoshi through a securities swap.

When making the announcement, Luis Merchan, the President and Chief Executive Officer (“CEO”) of Flora, noted:

“We are excited to increase our alignment with the Hoshi management team and believe the partnership will be much greater in scope than only using their Portugal and Malta facilities as a European importation gateway for our Colombian cannabis flower and derivatives” (https://cnw.fm/Yyygf).

Earlier in June this year, Flora had announced signing a Letter of Intent (“LOI”) for planning to make an initial strategic equity investment into Hoshi. Flora termed this as “the first of many steps to advance its plans to launch Flora-branded products across the world” (https://cnw.fm/XDa6T).

Having followed through with the investment, the company is now set to capitalize on Hoshi’s strong European presence. It is also bound to leverage the latter’s technical know-how, along with its understanding of the European market, to not only expand its market reach but also obtain its European Union Good Manufacturing Practices (“EU-GMP”) certification.

John Aird, the CEO of Hoshi, noted:

“We are excited to begin working alongside the Flora team and sharing our understanding of the European market while working together to bring to market finished product formats from Flora’s brand portfolio that are suitable for European medical consumers.

He further added:

“Not only has Flora made an investment into Hoshi, but through our securities swap, the Hoshi management team also has a vested interest in the success of Flora Growth and our long-term working relationship.”

Flora’s €2 million investment came with the following terms:

  • Flora would hold a right of first refusal to supply any cannabis oil or derivative products acquired by Hoshi or any of its affiliates at the processing facility in Malta. This will be subject to the parties entering into a definitive agreement by October 1, 2021
  • Flora would be Hoshi’s preferred supplier of genetic material and finished cannabis derivative products at its cultivation and processing facility in Portugal, subject to the two parties entering into a definitive agreement by October 1, 2021
  • Flora would be entitled to nominate one Director to Hoshi’s Board of Directors, specifically Luis Merchan, Flora’s President and CEO
  • Hoshi will use commercially reasonable efforts to grant Flora access to its EU-GMP auditors to assist Flora to obtain EU-GMP certification at its Cosechemos cultivation and extraction facility in Colombia

Hoshi is a fully integrated cannabis company that focuses on the European market. Its team comprises renowned cannabis entrepreneurs, hence its focus on developing and operationalizing assets across the global cannabis industry. Hoshi’s focus and emphasis are on cultivating, manufacturing, and distributing cannabis products throughout the EU. So far, the company is uniquely positioned to become the leading provider of cannabis and derivative products for this budding European market.

On the other hand, Flora is a cannabis cultivator, processor, and brand builder with a focus on the international market. It has made a name for itself by leveraging natural and cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions, including pharmaceuticals, hemp textiles, cosmetics, and food and beverage. Flora currently operates one of the world’s most extensive outdoor cultivation facilities, intending to market a higher-quality premium product at below-market prices.

2020 was a big year for the European medical cannabis industry. Germany’s imports of certified flower for medical purposes reached 9,231 kg, according to the Federal Institute for Drugs and Medical Devices. Between January and September 2020, the value of medical cannabis transactions in Germany alone amounted to €111 million, with flower sales accounting for 48.6% of these sales. Prohibition Partners has even projected that by 2024, over one million German patients will have access to medical cannabis, making Germany the leading European cannabis market in terms of growth.

It is further projected that the German medical cannabis market will be worth €7.7 billion by 2028. By the end of 2021, it is estimated that the entire European cannabis market will be valued at €403.4 million. By 2025, this industry is set to be valued at €3.2 billion, representing a compound annual growth rate (“CAGR”) of 67.4% between 2021 and 2025.

Flora hopes to capitalize on Hoshi’s understanding of and presence within the European market to capitalize on its strategic growth plans. Closing this investment is a step in the right direction and a first in Flora’s overall expansion plan to venture into the European market for its cannabis products.

For more information, visit the company’s website at www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Thursday, September 9th, 2021 Uncategorized Comments Off on $FLGC Inks Euro2M Investment in Hoshi As Part of its European Expansion Plan

$FLGC Announces Receipt of GMC Authorization Permitting Cosmetic Product Manufacturing

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced that it has received Good Manufacturing Practices (“GMP”) certification from the Colombian National Food and Drug Surveillance Institute (“INVIMA”) authorizing the manufacture of cosmetics products. Effective immediately, the GMP authorization allows Flora to offer cosmetic products for export to international markets that require goods meet the rigorous GMP standards. The authorization also recognizes the Flora lab for its quality procedures, which are in line with global pharmaceutical companies, and demonstrates the company’s operational excellence and capability of achieving pharmaceutical-grade standards. Those standards are recognized by regulators around the world as representative of high-quality products. According to the announcement, the certification is an essential component of Flora’s global supply chain strategy and distribution plan as the company plans to produce cosmetic products containing cannabinoids at its Colombian facility. The products will be branded for both the company’s Flora Beauty division and for white-label clients. FLGC’s lab currently holds three GMP certifications and produces an impressive portfolio of more than 190 products and 63 over-the-counter products that are registered and licensed with INVIMA. The company is looking to expand its more than distribution channels in Colombia and gain international clients as well. “Attaining this certification is a significant accomplishment for our team as it demonstrates our ability to achieve pharmaceutical-grade standards recognized by regulators throughout the world and producing consistent, safe, high-quality cosmetic products,” said Flora Growth president and CEO Luis Merchan in the press release. “Out of more than 650 cosmetics laboratories throughout Colombia, Flora Lab is only the 13th company to successfully navigate and implement the rigorous quality standards necessary to reach this level of manufacturing excellence. As we look to bring our premium brands and products to markets around the world, this certification represents a key component of our supply chain strategy and distribution plan. We can now pursue distribution agreements for the sale of cannabinoid and noncannabinoid containing cosmetic products in global markets where GMP certification is required for market access.”

To view the full press release, visit https://ibn.fm/Wd8u0

About Flora Growth Corp.

Flora Growth is a cannabis company that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. For more information about the company, please visit www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at http://ibn.fm/FLGC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, September 9th, 2021 Uncategorized Comments Off on $FLGC Announces Receipt of GMC Authorization Permitting Cosmetic Product Manufacturing

$BRSF New Clinical Guidelines for the Treatment of Brain Tumors Published

Researchers from the Medical University of Vienna have published clinical recommendations for the treatment and diagnosis of brain metastases from solid tumors. These joint recommendations include the latest methods for diagnosis, treatment, prevention and follow-up for brain metastases. They were drafted in partnership with experts from the European Society for Medical Oncology and the European Association of Neuro-Oncology.

The experts note that these guidelines are a valuable source of information for physicians and other service providers, as well as patients and their families. The guidelines were published in the “Annals of Oncology” journal.

Brain metastasis is common in cancer patients. For most patients, the objective of brain metastases treatment is to delay or prevent neurological deterioration to help prolong survival and improve the quality of life of patients. Of this number, only a few patients, especially those with small lesions, may experience total recovery.

Matthias Preusser, the lead author of the guidelines and the current president of the European Association of Neuro-Oncology, stated that the researchers had made significant progress in the biological treatment and diagnosis of brain metastases, as well as understanding brain metastases better. Preusser, who is also head of the  division of oncology head under the Department of Internal Medicine at the Medical University of Vienna, explained that the examination of tumor tissues was becoming important in the field of diagnostics as molecular analysis of cerebrospinal fluid or blood samples usually revealed genetic changes. which could be utilized as a basis for choosing targeted treatments.

Anna Berghoff, co-author of the study, explained that modern cancer treatments were personalized, noting that individually targeted immunotherapies and treatments were a therapeutic approach with great potential.

Preusser also explained that in the past few years, distinguishable successes had been achieved in treatment, as response rates were substantially increased in the treatment of brain metastases caused by skin cancer. He then noted that more than 55% of patients suffering from asymptomatic brain metastases of skin cancer could achieve sustained remissions in the brain after undergoing immunotherapy.

In addition to this, response rates above 50% had also been achieved with individualized treatments for brain metastases of breast cancer and lung cancer, particularly when gene amplifications or oncogenic mutations were present in the tumors. Preusser further explains that brain metastases were still one of the most severe situations in oncology. However, he asserted that advances in oncology based off of biological research were leading to better and longer survival for various patients, noting that these successes provided researchers with motivation to carry on with their research.

As brain diagnostics advance through the efforts of companies such as Brain Scientific Inc. (OTCQB: BRSF), it is likely to get easier to catch neurological conditions early when chances of complete healing are higher.

NOTE TO INVESTORS: The latest news and updates relating to Brain Scientific Inc. (OTCQB: BRSF) are available in the company’s newsroom at https://ibn.fm/BRSF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Thursday, September 9th, 2021 Uncategorized Comments Off on $BRSF New Clinical Guidelines for the Treatment of Brain Tumors Published

$PLTXF Announces Intention to Commence NCIB to Repurchase up to 5% of Its Common Shares

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced its intention to commence a normal course issuer bid (“NCIB”), under which the company may purchase up to 6,071,757 of its common shares, representing approximately 5% of its issued and outstanding common shares. PlantX indicated that it is commencing the NCIB because it believes that the market price of the common shares may not fully reflect the underlying value of the company’s business and future prospects. PlantX believes that the repurchase of its common shares for cancellation represents an appropriate use of the company’s financial resources and will enhance shareholder value. The NCIB is expected to commence on Sept. 15, 2021, and terminate on Sept. 14, 2022, with all common shares under the NCIB purchased on the open market through the facilities of the Canadian Securities Exchange.

To view the full press release, visit https://ibn.fm/NZjg4

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop shop for everything plant-based. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. In addition to offering meal and indoor plant deliveries, the company currently has plans underway to expand its product lines to include cosmetics, clothing and its own water brand — but the business is not limited to an e-commerce platform. The company uses its digital platform to build a community of like-minded consumers and, most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information, visit the company’s investor website at https://Investor.PlantX.com and visit PlantX’s YouTube channel.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at http://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, September 9th, 2021 Uncategorized Comments Off on $PLTXF Announces Intention to Commence NCIB to Repurchase up to 5% of Its Common Shares

$KAVL Manufacturing Partner Moves to Final Phase of Regulatory Authorization

Kaival Brands (NASDAQ: KAVL), a company focused on developing products into mature, dominant brands, is the exclusive global distributor of a portfolio of premium vape products manufactured by Bidi(R) Vapor LLC. Notably, the Bidi(R) Stick electronic nicotine delivery systems (“ENDS”) product lineup, offering 11 different flavors, followed a regulatory pathway that required the company to submit Premarket Tobacco Product Applications (“PMTAs”). The submission sought authorization to market specific tobacco products introduced after Feb. 15, 2007, unlike any of those previously grandfathered in. “Bidi’s PMTAs have passed the first two phases: received an acceptance letter from the FDA for the PMTA and subsequently received a filing letter indicating the application has met the FDA’s baseline criteria, allowing it to move into the final phase,” reads a recent article. “The ‘substantive’ phase involves the FDA’s scientific review of the PMTA and associated data. Bidi and Kaival are waiting for a final decision in the coming weeks, with an approval officially designating the products as ‘appropriate for the protection of public health.’”

To view the full article, visit https://ibn.fm/Ix1Si

About Kaival Brands Innovations Group Inc.

Based in Grant, Florida, Kaival Brands is a company focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets. The company’s vision is to develop internally, acquire, own, or exclusively distribute these innovative products and grow each into dominant market-share brands with superior quality and recognizable innovation. Kaival Brands is the exclusive global distributor of all products currently manufactured by Bidi(R) Vapor LLC, a leader in disposable electronic nicotine delivery systems (“ENDS”), and the company is poised to expand internationally. For more information, visit www.KaivalBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to KAVL are available in the company’s newsroom at http://ibn.fm/KAVL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, September 9th, 2021 Uncategorized Comments Off on $KAVL Manufacturing Partner Moves to Final Phase of Regulatory Authorization

$IWBB Is ‘One to Watch’

  • Investor appetite in Africa continues to be robust, attracting $407 billion of Foreign Direct Investments (“FDI”) between 2014 and 2018
  • Agriculture makes up 23 percent of sub-Saharan Africa’s GDP and 60 percent of employment
  • Tingo directly benefits the African economy by helping farmers gain better prices for their crops
  • The company enables more efficient markets via greater distribution of agricultural products
  • Tingo directly provides an access point to technology for tens of millions of Africans
  • The company is expanding into fintech banking services for the mass market, providing access to financial services through Tingo Pay, its proprietary mobile wallet application

Tingo (OTCQB: IWBB) is a digital service agri-fintech technology company focused on foundation-level agriculture and related financial services in Africa. The company aims to be Africa’s leading agri-fintech player, transforming rural farming communities to connect through its proprietary platform to meet their complete needs – from inputs and agronomy to off take and marketplace – and deliver sustainable income in an impactful way. The company’s vision is to build complete digitally inclusive ecosystems that promote financial inclusion and deliver disruptive micro-finance solutions, empower societies, produce social upliftment in rural communities and open international opportunities.

Tingo believes that a truly connected world will help contribute to a better global society. The company’s core focus areas are telecoms, financial services/fintech and agritech. Tingo’s goal is to provide a best-in-class customer experience, support the domestic economies of its host countries and support technological and financial inclusion to end the poverty premium. Through this, Tingo hopes to deliver attractive returns to shareholders while investing in the long-term future of the company and its subsidiaries.

Global climate change is challenging sustainable production and food security. Tingo’s strategy and market execution provide an opportunity for Africa to be a core focal point to solve a number of key areas of concern, including food security, gender equality, financial inclusion and poverty alleviation, to name a few. Disruption of micro finance through the use of DeFi-based stable coins and smart contracts will give agri-communities access to capital markets-driven digital finance solutions that make them more competitive and sustainable economically, striking a good balance of returns between digital asset providers and Tingo as the service partner. This innovation will deliver significant access to much needed finance at ‘Grassroot’ levels, delivering tangible social upliftment and GDP growth in the African markets served by Tingo.

Tingo Mobile, with more than nine million subscribers, is Nigeria’s leading technology and device-as-a-service platform aimed at accelerating digital commerce, especially in the country’s agritech and fintech verticals. The company helps farmers acquire mobile phones through a unique leasing plan, connecting them to mobile and data networks through its own virtual mobile network. Tingo also connects farmers to markets, services and resources via Nwassa, its digital agritech marketplace platform that commenced operations in 2020. The company has also launched a beta version of TingoPay – a B2B and B2C fintech app aimed at providing financial services to users inside and outside of the agriculture value chain. Among the services offered are mobile wallets, payment processing and access to specialist lenders, insurers and pension products.

Tingo will soon announce its innovative blockchain-based solution for use of digital stable coins to empower frictionless trade across borders in Africa. The company’s market-proven model in Nigeria is its core foundation, enabling Tingo to deliver the same service model across Africa to become the continent’s leading agri-fintech business powered through smartphone technology.

The African Continental Free Trade (“ACFT”) plan will be a key framework to prepare the company to be the leading intra-Africa trading hub for trade flows across Africa in the medium term, when it is likely the agreement will be executed into tangible activity. Tingo is well positioned to easily transform the goals of the ACFT into reality when finally implemented by the African Union and the various African countries that have not signed up.

Tingo posted total revenue of $594 million in 2020, with $212 million EBITDA. As of December 31, 2020, Tingo has 9,344,000 subscribers. The company is confident that these figures will grow through its expansion across Africa and natural progression of business in Nigeria.

Businesses

Tingo has four core businesses:

  • Mobile Phone Leasing – Tingo has distributed almost 30 million mobile handsets since 2014 and will continue to replace the devices of its installed customer base every three years. Tingo Mobile provides the latest mobile phone handsets at an affordable price point and allows customers to spread payments over 36 months.
  • Mobile Voice and Data Service – Through a mobile virtual network, Tingo provides its customers with voice and data services, allowing customers to communicate effectively, both inside and outside the agricultural ecosystem.
  • Nwassa Marketplace Platform – Nwassa is Tingo’s proprietary agritech platform which provides Africa’s farmers with access to global markets to secure more competitive pricing for their crops. The platform processes 500,000 daily transactions with a value of over $8 million. A select group of trusted partners can assist smallholder farmers and agricultural cooperatives with packaging, warehousing, and dry and wet cargo logistics, as well as up-to-date information from the global agricultural sector. Tingo provides its customers with digital wallet services, which enable them to send and receive domestic payments, monitor cash flow in real time and securely hold money. The company also provides access to other services, such as utility bill payment, virtual airtime top-up, insurance services and alternative lending solutions.
  • TingoPay – Since the launch of the Nwassa platform, Tingo has been a dominant player in the B2B fintech vertical. After many successful months of operating Nwassa, Tingo entered the fintech B2C vertical to extend its B2B offering to a broader market beyond agriculture.

TingoPay is still in its beta phase and will launch in 2021 with a comprehensive marketing campaign. TingoPay offers the following services:

  • Tingo Wallet top-up
  • Peer to Peer payments, inclusive of merchant payments at the stores
  • Utility payments – airtime, broadband, cable, electricity, water, hotel, flights etc.
  • Pension payments
  • QR code payment services

Market Opportunity

Africa is the second-largest continent by population. It is also the youngest by far, with a median age of 18 for its 1.3 billion people. Tingo believes the building blocks for growth in Africa’s agriculture industry are in place and that the company is well positioned to participate in the upside. Sub-Saharan Africa’s population is growing at a rate of 2.7 percent per year. At the current growth rate, the continent’s population will double by 2050. Africa’s youthfulness represents a significant opportunity for material growth in demand for agricultural commodities. This younger generation is also being born into a digital world and is comfortable using technology.

Africa’s governments are improving business conditions for entrepreneurs and small businesses. Sub-Saharan Africa’s World Bank Doing Business rank has improved from 45 in 2004 to 65 in 2020. Tingo believes this trend will continue and encourage establishment of more new ventures across all economic sectors, including agriculture.

Africa attracted $407 billion of Foreign Direct Investments (“FDI”) between 2014 and 2018. Investments are increasingly focused on services and industrial sectors. Only 20 percent of investments are in extractive industries – a clear reversal from 2008, when 55 percent of FDI was aimed at resource extraction. Tingo believes FDI into Africa will help resolve significant infrastructure constraints and create value for agribusiness.

Management Team

Dozy Mmobuosi is the CEO of Tingo. He cofounded Tingo Mobile PLC (Nigeria) in 2001 and led the design and launch of Nigeria’s first SMS banking solution, which is still in use in the country today. He also headed a team of more than 120 Chinese and Nigerian engineers in the construction of two mobile phone assembly plants in Nigeria, which have produced and distributed 20 million phones across the country. He has led Tingo’s growth to more than $600 million in revenue annually. He holds a Ph.D. in Rural Advancement from UPM Malaysia.

Dakshesh Patel is the CFO of Tingo. He was formerly CFO of NatWest’s Global Debt and Investment Banking division. He has served as a Director at Gerken Capital Associates, a San Francisco-based alternative asset fund manager. He also led the restructure of Lloyds Banking Group (last financial crisis); managed integration of two leading shipping groups’ global treasury function to create world-leading shipping group Maersk Shipping; built three fintech companies; and exited one to Worldpay. Mr. Patel has strong banking experience, with a focus on Africa. He is a chartered accountant.

Chris Cleverly is president of Tingo. He has served as CEO of the Made in Africa Foundation, and as CEO of blockchain payments gateway startup Kamari. He has been a board member of several companies, both public and private, in the UK, India, China and Africa. He has advised multiple UK companies on their entrance into African markets, and regularly advises the UK Government on development issues and African governments on investment issues.

Clarence Simms is the Chief Technology Officer at Tingo. He has 25 years of IT and IT management experience. He has worked in IT Shared Services Technical Operations and IT Program Management for Huawei Technologies and MTN. As an entrepreneur, he created Africaprepay.com, a service that allows African Diaspora travelers to send airtime, pay bills, send mobile money and transfer money to a bank account from anyplace in the world.

Rory Bowen is the Chief of Staff at Tingo. Mr. Bowen started his career in traditional capital and derivatives markets working for Moneycorp and Tradition UK in European and emerging markets across FX, interest rate derivative and government bond markets. He has also spent time with one of Europe’s fastest growing fintech’s banking circles. Before joining Tingo, he was Chief of Staff at FinTech Alliance, an organization established in partnership with the UK Government Department for International Trade to foster innovation, growth and foreign direct investment (“FDI”) in the financial services sector and facilitate greater public/private cooperation.

For more information, visit the company’s website at www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to IWBB are available in the company’s newsroom at https://ccw.fm/IWBB

About CryptoCurrencyWire (“CCW”)

CryptoCurrencyWire (CCW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with CCW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, CCW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CCW brings its clients unparalleled visibility, recognition and brand awareness.

To receive instant SMS alerts, text CRYPTO to 77948 (U.S. Mobile Phones Only)

CryptoCurrencyNewsWire is where News, content and information converge via Crypto.

For more information, please visit https://www.CryptoCurrencyWire.com

Please see full terms of use and disclaimers on the CryptoCurrencyWire (CCW) website applicable to all content provided by CCW, wherever published or re-published: http://CCW.fm/Disclaimer

CryptoCurrencyWire (CCW)
New York, New York
www.CryptoCurrencyWire.com
212.994.9818 Office
Editor@CryptoCurrencyWire.com

CryptoCurrencyWire is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $IWBB Is ‘One to Watch’

$WTER Announces 228% Increase in C-Store Sales

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and The Clean Beverage Company(TM), has announced that this year’s sales in the all-important c-store channel have more than doubled over the previous year. The company attributes much of the growth to partnerships with several new major direct-store-delivery (“DSD”) providers as well as additional placements in six new distribution centers of legacy partners. “Our c-store channel sales are beginning to grow significantly. Last month alone, we grew by almost 300% in c-store sales, making it by far our most successful month in the company’s history. This is before the full impact of any of our new DSDs or six new distribution centers has even been felt,” said Richard A. Wright, president and CEO of The Alkaline Water Company. “The Alkaline88 footprint continues to expand with each new distribution center added to our nationwide network. Recent additions to our network of distributors include Nassau Candy, Cooper Booth Wholesale, Hensley Beverage Company, Nevada Beverage Company, and National Convenience Distributors. Combined with our legacy partners, our network’s access now gives us the potential to service approximately 50,000 of the 150,000 convenience stores across the country. Between our traditional channels and c-stores, our single serves are now available to more customers than ever before. Many of our single-serve SKUs, including our aluminum bottle and many of our flavored-infused waters, are on pace to significantly outperform their sales from last year. The c-store channel is a leader in bottled water sales with over $4.5 billion in sales last year, according to Convenience Store News. While we continue to see significant growth in our traditional channels, we anticipate that the convenience channel will meaningfully contribute to our fiscal year 2022 sales revenues.”

To view the full press release, visit https://ibn.fm/1Tquo

About The Alkaline Water Company

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in six unique, all-natural flavors with new flavors coming soon. In 2021, The Alkaline Water Company was pleased to welcome Shaquille O’Neal to its board of advisors and to serve as the celebrity brand ambassador for the Alklaine88 and A88 Infused brands. To purchase Alkaline88 and A88 Flavor Infused products online, visit www.Alkaline88.com. To learn more about the company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $WTER Announces 228% Increase in C-Store Sales

$VVOS to Participate at H.C. Wainwright 23rd Annual Global Investment Conference

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from mild-to-moderate obstructive sleep apnea (“OSA”) and snoring, today announced its participation at the H.C. Wainwright 23rd Annual Global Investment Conference. Vivos CEO Kirk Huntsman will be presenting at the event beginning at 7:00 a.m. EDT on Monday, Sept. 13, 2021. Interested institutional or retail investors should visit https://ibn.fm/VL1jk to register for the conference and may listen to the company’s presentation online at https://ibn.fm/YuFWj.A replay of the presentation will be available via the Investor Relations page of the company’s website.

To view the full press release, visit https://ibn.fm/2M9w3

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for adult patients suffering from mild-to-moderate obstructive sleep apnea (“OSA”). The Vivos treatment involves customized oral appliances and treatment protocols called the Vivos System. Vivos believes that its Vivos System oral appliance technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for adults with mild-to-moderate OSA. Vivos also sells orthodontic appliances for adults and children. Vivos’ oral appliances have proven effective in over 19,000 patients treated worldwide by more than 1,250 trained dentists. Combining proprietary technologies and protocols that alter the size, shape and position of the tissues that comprise a patient’s upper airway, the Vivos System opens airway space and may significantly reduce symptoms and conditions associated with mild-to-moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes VivosScore, powered by the SleepImage diagnostic technology, for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentists training and other value-added services in connection with using the Vivos System. For more information, visit www.VivosLife.com.

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $VVOS to Participate at H.C. Wainwright 23rd Annual Global Investment Conference

$SRAX Announces Keynote Speakers for 2021 Sequire EdTech Conference

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, will host a stellar list of keynote speakers for is upcoming edtech event. The 2021 Sequire EdTech Conference is slated for Sept. 13, 2021, from 11:30 a.m.–5:30 p.m. ET. This year’s event features an impressive slate of main speakers, including Patrick Brothers, cofounder and co-CEO of HolonIQ, a global market intelligence platform for education; Gagan Biyani, cofounder of Udemy, an online education company; Ann Marie Sastry, CEO of Amesite, an award-winning artificial intelligence software company focused on improving learning; Barbie Brewer, chief people officer at Netflix and board member at Amesite; Mary Juhas, associate vice president at The Ohio State University; Julia Pugachevsky, education editor at Insider; and Jonathan Satchell, CEO of Learning Technologies Group, a global, fast-growing, full-service digital learning and talent management company. In addition to these keynote addresses, the one-day investor event will include presentations from more than 10 virtual work and learning companies.

To register for the event, visit https://ibn.fm/LpUQK

To view the full press release, visit https://ibn.fm/6Nq3d

About SRAX Inc.

SRAX is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information about the company, please visit www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $SRAX Announces Keynote Speakers for 2021 Sequire EdTech Conference

$RWBYF 420 with CNW – Trials on Marijuana-Based Treatments for Gynecological Conditions to Begin in 2022

Clinical trials to examine the effectiveness and safety of marijuana-based treatments for various gynecological conditions are expected to begin early next year. The trials will evaluate marijuana-based pharmacology products developed by Gynica, a female technology startup company based in Jerusalem.

The startup believes that the plant’s active ingredients can help ease painful gynecological conditions, including endometriosis and painful menstruation, which is also known as dysmenorrhea. Traditional treatments, such as hormone therapy, over-the-counter painkillers and surgical intervention. can be inadequate and pose their own health risks, as in the case of endometriosis.

Endometriosis is a disorder which causes tissues that normally line the uterus, known as the endometrium, to grow outside the uterus. These tissues usually become trapped inside the body and thicken, causing a build-up of adhesions and scar tissue. This results in excessive bleeding, painful intercourse and painful menstruation. In some cases, endometriosis can cause infertility.

Endometriosis has no definitive cause and no cure. It takes between 6 to 10 years for the disorder to be properly diagnosed, despite the fact that it affects every 1 in 10 women of reproductive age globally. This equates to about 180 million girls and women around the globe.

Gynica hopes to meet these unaddressed needs in women’s health by developing marijuana-based solutions for these gynecological conditions.

The CEO and co-founder of the start-up, Yotam Hod, stated that there exists so many gaps in how conditions that affect women are handled by both the scientific community and the medical community. The company has developed proprietary vaginal suppositories, which Hod says have been designed to decrease pain as well as inflammation, which is a key factor in both dysmenorrhea and endometriosis.

Dysmenorrhea is also common, with physicians noting that the associated pain varies between mild and severe. It is estimated that between 40% and 95% of women of reproductive age suffer from dysmenorrhea. Physicians note that for some individuals, dysmenorrhea and endometriosis are related.

Gynica believes that endometriosis and dysmenorrhea may be associated with a deficiency in the endocannabinoid system. The company references published research, which states that, after the brain, the female reproductive system is the region with the most endocannabinoid receptors. The endocannabinoid system is comprised of natural marijuana-like molecules produced by the human body, which regulate processes such as reproductive function, sleep, mood, appetite and pain.

Hod notes that their solutions show promise for treating these conditions and maintains that cannabinoid-based treatments may provide an improved solution for women who suffer from these conditions.

If successful, these trials could lend further credence to the profile of marijuana as a medicinal plant. The entire cannabis sector, including companies such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF), could benefit from the positive news such outcomes would trigger.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $RWBYF 420 with CNW – Trials on Marijuana-Based Treatments for Gynecological Conditions to Begin in 2022

$NEXCF to Release New SaaS Offering Next Month

Nextech AR Solutions (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29), a diversified leading provider of augmented reality (“AR”) experience technologies and services, has announced a release date for its AR for ecommerce offering. The company noted that the solution will be available as a self-service SaaS by next month. According to the announcement, Nextech anticipates its platform will be the first true self-service AR SaaS option that will be affordable for all ecommerce sites. Nextech’s proprietary technology is already being used by major retail players, including Kohls, Pier1 and K-Mart Australia, which are offering AR shopping experiences that allow their customers to visualize a product in a personalized environment. This “try before they buy” approach is fueling enthusiastic adoption of AR for ecommerce as it demonstrates higher online conversion rates. Nextech reported that tens of thousands of consumers are seeing its 3D models, with more than 330,000 AR experiences provided last month alone. The release of the industry’s first low-cost, self-serve SaaS platform will make the same technology and experiences available to small and medium-size ecommerce sites. “Up until now, 3D models have been built individually by highly specialized 3D designers, with high price points and long wait times to match,” said Nextech CEO Evan Gappelberg in the press release. “With the rise in WebAR for ecommerce, the demand to scale and create high-quality 3D content continues to accelerate and is expected to be standard in ecommerce shopping in 2022 and beyond. With our AI-driven, 3D content-creation capabilities, and now our low-cost, monthly fee-based SaaS platform, we are addressing this growing market demand and unblocking the 3D content-creation bottleneck head on. In 2021 with Threedy.ai, we will exceed our production of 3D models in all previous years combined by a factor of 10.”

To view the full press release, visit https://ibn.fm/HcRgS

About Nextech AR Solutions Corp.

Nextech develops and operates augmented reality (“AR”) platforms that transport three-dimensional (“3D”) product visualizations, human holograms and 360-degree portals to its audiences altering e-commerce, digital advertising, hybrid virtual events (events held in a digital format blended with in-person attendance) and learning and training experiences.

NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at http://ibn.fm/NEXCF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $NEXCF to Release New SaaS Offering Next Month

$NETE CNBC Test Confirms US EV Charging Network Still Woefully Inadequate

The government is determined to replace the fossil fuel vehicles on the roads with zero-emission electric vehicles (“EVs”), so much so that President Joseph Biden recently announced that his administration was aiming to achieve 50% electric vehicle sales by 2030. Automakers are already on board, including EV startups and companies that have been around for a while, such as Ford and Mercedes. In addition, we are likely to see more than two dozen new EV models in the next few years. However, thanks to America’s inadequate public charging infrastructure, range anxiety and charging are among the most significant barriers to EV adoption in the country.

At the moment, the United States has a measly 43,800 charging stations compared to 136,000 gas stations, according to the U.S. Department of Energy, and most of them are concentrated in urban areas. On top of that, only 5,000 can be considered fast chargers, which can take approximately 45 minutes or more to recharge an EV, while the majority of public chargers are Level 2 chargers that take five to six hours to recharge compared to gas stations, which take a few minutes.

To experience firsthand just how lacking America’s EV charging infrastructure is, CNBC’s Brian Sullivan and Harriet Taylor took an eight-hour road trip from Southern California to San Francisco in a rented Polestar 2 with a 265-mile range.

The pair started their journey at Enterprise, California, driving 60 miles to Mountain Pass, California, arriving around 5 p.m. on a hot Tuesday afternoon. They first had to download PlugShare, an app that shows where every charging station is —  whether it is available or not. Sullivan and Taylor then traveled 98 miles to Barstow, California, where they recharged at Electrify America, a location with eight chargers. Charging took 37 minutes at a total cost of $13.33. After that, they headed to Bakersfield, California, 138 miles away and arrived with just 18% charge to spare. They checked into a Hampton Inn that had only two plugs; they charged their car overnight for 10 hours, reaching a 90% charge.

Another 128 miles left them at Firebaugh, California, with 24% charge left in the tank. They plugged the Polestar into an Electrify America station at a Shell gas station, and after 41 minutes and $21.93, the EV was at 87% charge and raring to go on the final leg of the trip. The two drove 115 miles to Sunnyvale, California, arriving with 24%, which was topped off to 87% after 39 minutes of charging. Sullivan then dropped Taylor off at San Francisco Airport before heading to the CNBC studio with 67% charge, arriving at the studio with 42% left in the tank.

The journey showed Sullivan that while an EV road trip isn’t impossible, it isn’t easy either and requires significant planning and preparation. EV chargers are plentiful for the current number of EVs, especially when you plan your route well, but as the number of EVs on the road increase, the current infrastructure will be unable to meet demand. The biggest issue, however, is the time it takes to charge. Sullivan and Taylor were lucky to find a free charger at each station, but an influx of EVs will put so much pressure on the infrastructure that drivers will potentially be waiting hours to recharge.

The road trip test conducted by CNBC makes it abundantly clear that EV sector players such as Net Element (NASDAQ: NETE) and other stakeholders have their work cut out if they are to ensure that the inadequacy of charging facilities doesn’t slow down the uptake of EVs.

NOTE TO INVESTORS: The latest news and updates relating to Net Element (NASDAQ: NETE) are available in the company’s newsroom at http://ibn.fm/NETE

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $NETE CNBC Test Confirms US EV Charging Network Still Woefully Inadequate

$LEXX is Changing Absorption of Fat-Soluble Compounds Through Patented DehydraTECH(TM) Technology

  • Lexaria Bioscience Corp. and its patented DehydraTECH technology promote a more effective, less expensive form of oral drug delivery evaluated thoroughly in vivo, in vitro, and human clinical testing
  • DehydraTECH is sub-licensed to other companies in select countries, and is in close collaboration with the largest R&D organization in Canada, the National Research Council, since January 2017
  • The technology is suitable for use with a wide range of product formats, including pharmaceuticals, nutraceuticals, consumer packaged goods, and over-the-counter (“OTC”) capsules, pills, tablets, and oral suspensions
  • DehydraTECH-enabled drugs offer multiple benefits, including faster delivery, increased bioavailability, increased brain absorption, improved drug potency, reduced administration costs, and masking unwanted taste without the use of additional sweeteners.

As an innovator of drug delivery methods, Lexaria Bioscience (NASDAQ: LEXX) and its patented DehydraTECH are improving the speed and efficiency of orally delivered fat-soluble active molecules and drugs. Lexaria Bioscience is advancing its IP for transforming existing consumer products and medications that may improve availability and bioavailability. DehydraTECH promotes a more effective, less expensive form of oral drug delivery evaluated thoroughly in vivo, in vitro, and human clinical testing.

Lexaria Bioscience operates four subsidiary companies focused on different commercial opportunities within their respective industries – Lexaria Pharma Corp., Lexaria Nicotine Corp. (16.67% owned by Altria Ventures Inc.), Lexaria Hemp Corp., and Lexaria Canpharm Corp. The DehydraTECH technology is also sub-licensed to other companies in select countries. The Company also has a collaborative research agreement with the National Research Council (“NRC”), Canada’s premier research and technology organization.

Lexaria Pharma Corp. – investigates new products for high blood pressure (hypertension), antiviral therapy, and other drug classes.

Lexaria Nicotine Corp. – investigates oral non-combusted tobacco-derived nicotine product formats.

Lexaria Hemp Corp. – pursues business-to-business (“B2B”) opportunities, with cannabinoids like cannabidiol (“CBD”).

Lexaria Canpharm Corp. – operates a state-of-the-art Health Canada-licensed laboratory that can develop novel psychotropic cannabinoid formulations for commercialization in sectors where it is federally legal.

The DehydraTECH technology is suitable for use with a wide range of product formats. These include pharmaceuticals, nutraceuticals, consumer packaged goods, and over-the-counter (“OTC”) capsules, pills, tablets, and oral suspensions. The technology was specifically designed for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients into a more easily absorbable format, allowing them to enter the bloodstream more quickly and effectively.

The use of DehydraTECH-enabled drugs or consumer products offers the following benefits:

  • Speeds up delivery: effects can be felt by consumers in a matter of minutes
  • Increases bioavailability: more effective at delivering drug or product into the consumer’s bloodstream
  • Increases brain absorption: animal testing has suggested significant improvement in the quality of the drug delivered across the blood-brain barrier
  • Improves drug potency: more of the ingested product is made available to the body, requiring lower dosages to achieve the desired effects
  • Reduces drug administration costs: lower dosages mean overall lower drug costs
  • Masks unwanted taste: technology eliminates or reduces the need for sweeteners

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to ten times, reducing the onset time from one to two hours to just minutes – masking unwanted tastes. The technology will be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”), and nicotine.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have a questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $LEXX is Changing Absorption of Fat-Soluble Compounds Through Patented DehydraTECH(TM) Technology

$INM Slated for Live Webcast at VirtualInvestorConferences.com

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol (“CBN”), will be featured at the upcoming VirtualInvestorConferences.com. InMed president and CEO is scheduled to present a real-time, interactive presentations during the two-day conference; InMed’s presentation will start at 1:30 p.m. ET on Sept. 8, 2021. During the presentation Adams will provide an overview of the company’s recent highlights as well as answer questions from potential investors in real time. Company highlights include the announcement that it has increased the yield of its proprietary IntegraSyn(TM) rare cannabinoid manufacturing approach to 5 g/L, further improving the overall economics in advance of commercial-scale production and that it has signed a nonbinding letter of intent to acquire BayMedica, a private company that specializes in the manufacture and commercialization of rare cannabinoids. In addition, as part of a phase 2 clinical trial, InMed has filed clinical trial applications in several countries. Virtual Investor Conferences (“VIC”) has developed a reputation for being a leading proprietary investor conference series; VIC events provide an interactive forum for publicly traded companies to meet and present directly with investors.

To register for the event, visit https://ibn.fm/0HHBZ

To view the full press release, visit https://ibn.fm/gYYIo

About InMed Pharmaceuticals Inc.

InMed is a clinical-stage pharmaceutical company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (“CBN”) and is developing IntegraSyn to produce pharmaceutical-grade cannabinoids. The company is dedicated to delivering new therapeutic alternatives to patients who may benefit from cannabinoid-based pharmaceutical drugs. For more information, please visit www.InMedPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at http://ibn.fm/INM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $INM Slated for Live Webcast at VirtualInvestorConferences.com

$IDEX Completes Commercial EV Ecosystem Reach through M&A Deal with Van Manufacturer VIA

  • Sustainability cultivator Ideanomics has reached an agreement with commercial EV vehicle manufacturer VIA Motors to acquire VIA in an all-stock transaction valued at $450 million
  • The VIA acquisition will solidify Ideanomics’ position as a made-in-America brand focused on building an end-to-end commercial EV ecosystem
  • Ideanomics has completed other M&A activity in recent months designed to establish sustainable solutions that reduce the harmful effects of pollutants on the earth’s climate, particularly involving wireless battery-charging technology for commercial fleets
  • The acquisition will help VIA to focus on completing the manufacturing process, with vehicles expected to roll out by 2023

New York-based Ideanomics (NASDAQ: IDEX) has been making a name for itself as a commercial electric vehicle (“EV”) industry innovator and on Aug. 30 the company announced an agreement it expects to be “transformative” in Ideanomics’ pursuit of providing end-to-end services for the commercial EV market.

Ideanomics’ planned 100 percent acquisition of Utah’s VIA Motors International, Inc. in an all-stock transaction is expected to grant Ideanomics a vehicle manufacturing element to complement its charging technologies for “an immediate leadership position in a rapidly growing market” and deliver another revenue path to growth and profitability, Ideanomics CEO Alf Poor said in a morning conference call before market opening Aug. 30.

“With Via we’re going to make the vehicles. Through our forced induction charging system with WAVE we’re going to be able to charge [them], through our relationship with [Germany’s Prettl Electronics Automotive] we’re going to be able to have outside battery storage to charge any type of fleets outside of a normal grid, and many other aspects, [to create a] complete ecosystem for Ideanomics,” Board Executive Chairman Shane McMahon said during the conference call (https://ibn.fm/3jcXs).

Via will make electric commercial vehicles including Class 2 through Class 5 cargo vans, trucks, and buses. The company’s CEO is Bob Purcell, who led the General Motors (“GM”) electric vehicle business in the 1990s and is known as “the father of the legendary GM EV1,” which was the first mass-produced EV.

“We were the car that started it all. … I was very proud of my group,” Purcell said in a Barron’s interview about the deal (https://ibn.fm/7lT7v). “We invented that technology … things like torque vector control for motors, battery management systems…none of that existed before the EV1.”

The agreement cements Ideanomics as a made-in-America brand and values VIA at $450 million, according to the news release announcing the agreement (https://ibn.fm/lS950). Poor told investors during the conference call that revenue forecasts for the acquisition will be announced in the near future as part of the proxy for shareholders.

Under the terms of the agreement, VIA shareholders will receive about 162 million shares of Ideanomics common stock after the application of certain purchase price adjustments, leaving VIA shareholders with ownership of about 25 percent of the combined company.

Ideanomics is separately advancing $50 million of financing to VIA in the form of a secured convertible note, according to the news release.

Production is planned for 2023, according to Barron’s.

“What they needed was a partner that could help them, allow them to focus on execution. Because execution is going to be the difference between who gets market share and who doesn’t,” Poor said.

For more information, visit the company’s website at www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $IDEX Completes Commercial EV Ecosystem Reach through M&A Deal with Van Manufacturer VIA

$FLGC Collaborates to Launch Cutting-Edge Global Cannabis Product Validation, Authentication Platform

Flora Growth Corp. (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its entry into agreements with TruTrace Technologies Inc. (CSE: TTT) (OTCQB: TTTSF) and Applied DNA Sciences Inc. (NASDAQ: APDN) to launch a complete and differentiated global cannabis product validation and authentication platform for consumers, distributors and government regulators. The initiative further demonstrates Flora’s commitment to operational excellence and transparency enabling immutable genome-to-sale supply chain validation for domestic and international trading partners and government regulators. “In today’s globalized market, supply chain provenance is becoming an increasingly important component for every major international CPG company. This is particularly true for the cannabis industry, where concerns over the sale and distribution of products from the illicit market persist for businesses,” said Jason Warnock, Flora Growth’s chief revenue officer. “Flora anticipates that the added assurance, efficiency and transparency brought by these technologies will optimize our value proposition to customers, differentiate us from peers and increase our sales opportunities.”

To view the full press release, visit https://ibn.fm/pFIsk

About Flora Growth Corp.

Flora is a cannabis company that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. Visit www.FloraGrowth.ca or follow @floragrowthcorp on social for more information.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at http://ibn.fm/FLGC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $FLGC Collaborates to Launch Cutting-Edge Global Cannabis Product Validation, Authentication Platform

$CNSP Dog Study May Offer Insight into How Gliomas Impact the Immune System

recently conducted study has found that in comparison with low-grade gliomas, high-grade gliomas in canines contain more immune cells linked to suppressing immune response. The study adds to evidence suggesting that these tumors may recruit immune cells which assist with immunosuppression. Its findings may be useful in the development of future glioma treatments for both dogs and humans.

Gliomas are caused by support cells known as glial cells, which mutate and become cancerous. These cells are usually located throughout the spinal cord and brain. In canines, gliomas make up nearly 35% of all intracranial cancers and are the second most common tumor type in the central nervous system. The average rate of survival for dogs with gliomas who undergo radiation therapy ranges between 9 to 14 months, which is akin to the 14-month rate of survival for humans who undergo chemotherapy, radiation and surgery as part of their treatment for gliomas.

The main types of canine glioma include undefined glioma, astrocytoma and oligodendroglioma. Each type is classified as high- or low-grade based on the microscopic features present.

Immunotherapy treatments make use of an individual’s immune system to fight cancer. This treatment has shown promise in treating various types of cancer but hasn’t been successful in treating gliomas in people as this particular type of cancer suppresses the immune system to allow the tumor to grow. Scientists are working towards better understanding the interaction between the immune system and gliomas, with the objective being to improve therapeutic outcomes.

The study was conducted by a research team comprising of researchers from various institutions who examined more than 70 different gliomas that had been acquired from veterinary patients seen between 2006 and 2018 at the North Carolina State College of Veterinary Medicine. The team used computerized image and immune-histochemical tagging analysis to identify the numbers of every type of immune cell in each tumor. The immune cells included macrophages, regulatory T lymphocytes, T lymphocytes and B lymphocytes.

The researchers discovered that there were higher numbers of polarized macrophages and regulatory T lymphocytes in high grade tumors, in comparison with low-grade tumors.

The first author of the study, Gregory Krane, explained that in healthy people, regulatory T lymphocytes prevented autoimmune ailments. However, cancer sometimes recruited and activated these cells to prevent the immune system from fighting tumors. This is why regulatory T lypmhocytes were found to be higher in high-grade gliomas, in comparison with the numbers found in low-grade gliomas.

Krane hopes that the study will afford researchers more insights into how gliomas affect the immune system and in the long run, help in the development of better treatments for gliomas.

In the meantime, companies such as CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are working to develop superior remedies for the malignancies that impact the central nervous system as well as the brain.

NOTE TO INVESTORS: The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company’s newsroom at https://ibn.fm/CNSP

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $CNSP Dog Study May Offer Insight into How Gliomas Impact the Immune System

$ANPC Symposium Highlights the Application of Biophysical Technology in Cancer Prevention and Treatment

  • AnPac Bio-Medical Science Co., Ltd. held its 2021 technical symposium, entitled “The Applications of Biophysical Technology in Cancer Prevention and Treatment” in Shanghai, China, on August 6, 2021
  • The symposium included attendees from various hospitals, universities, and Fortune 500 companies, including Thermo Fisher Scientific and AnPac Bio’s contract partner Roche Pharmaceuticals China
  • A recent report from Frost & Sullivan ranked AnPac Bio at #3 in the world and 1st  in China for the number of clinical samples analyzed amongst companies that offer next-generation early cancer screening and detection technology

AnPac Bio-Medical Science (NASDAQ: ANPC) recently held its 2021 technical symposium entitled “The Applications of Biophysical Technology in Cancer Prevention and Treatment.” The symposium was held in Shanghai, China, and was attended by life science Fortune 500 companies such as Thermo Fisher Scientific and Roche Pharmaceuticals.

Experts came together to discuss emerging cancer prevention and treatment theories and technologies, including the applications of biophysical technology to address these needs. Measurement of biophysical properties is the basis for Anpac Bio’s novel CDA technology. The Company’s CDA technology can rapidly detect 26 different types of cancers with a simple blood test.

Talking points of the symposium included the newly announced cooperation between AnPac Bio and Roche Pharmaceutical China, as well as Thermo Fisher Scientific’s latest developments in in-vitro diagnosis (“IVD”), and the clinical trials that have been held on AnPac Bio’s proprietary cancer differentiation analysis (“CDA”) technology, including recently unblinded and analyzed clinical data.

AnPac Bio is one of the first companies in the world to produce major theories and methods of multi-level, multi-parameter, and multi-cancer screening. The innovative technology has opened up a new field in early cancer screening that is based on a biophysical properties and has achieved significant results. In 2019, Frost & Sullivan ranked AnPac Bio third in the world and first in China among those companies in the region in terms of the number of clinical samples offering next-generation early cancer screening and detection.

With one of the largest sample libraries in the world and more than 220,000 samples tested, AnPac Bio is an innovative leader in the field. The company’s CDA technology has shown to be advantageous over traditional detection methods, allowing it to outperform in the early detection market. The company’s main goal for 2021 is to extend its major discoveries in the field of early cancer detection and also develop cancer treatment technologies.

“This technical symposium allowed people to better understand the most cutting-edge applications of biophysical technology in cancer prevention and treatment, and it also played an important role in promoting future research and development in cancer prevention and treatment,” Dr. Chris Yu, CEO and Chairman of AnPac Bio, said. “As a pioneer in the application of biophysics to cancer prevention and treatment, AnPac Bio continues to report new ideas and cutting-edge technology to the public, sharing the latest clinical study and trial results, and continuing to promote collaborations between industry, and academia.”

AnPac Bio has proven to be an early thought leader and developer of multi-cancer (also called pan-cancer) ideas and technology. The company’s patent applications and IP began in the early 2010’s, and by 2014 it had already announced a cancer screening product with the capability of screening 16 types of cancer earlier than anyone else in the industry.

AnPac Bio’s CDA technology combines the assessment of existing biomarkers with the biophysical properties and cellular proteins that signal the lead up to serious health conditions (including cancer). The technology can also be used to pinpoint the most likely location for cancer or predict where the risk will be high in the future. Having invented and championed the idea and method of “multi-level, multi-parameter” cancer screening, AnPac Bio’s contributions are now recognized and accepted by leading United States medical institutions and life science companies.

For more information, visit the company’s website at www.AnPacBio.com.

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $ANPC Symposium Highlights the Application of Biophysical Technology in Cancer Prevention and Treatment